BioBlast Pharma

22.03.2016 | NASDAQ

ZAG-S&W represented BioBlast Pharma Ltd.

Attorneys Oded Har-Even, Shy Baranov, Robert Condon, David Huberman and Hila Nahum represented the company as issuer’s counsel in a certain registered direct offering for an aggregate price of $6.7M. Roth Capital and Rodman & Renshaw acted as co-placement agents for the offering.




Recent Activity